Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis
暂无分享,去创建一个
Anurag S Rathore | Kurt A Brorson | Sumit Kumar Singh | Mili Pathak | Erik K Read | Cyrus D Agarabi | Mansoor Khan | M. Khan | C. Agarabi | E. Read | K. Brorson | A. Rathore | Mili Pathak | Sumit Kumar Singh
[1] T. Raju,et al. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. , 2008, Current opinion in immunology.
[2] Pradip K. Roychoudhury,et al. Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell , 2013, Cytotechnology.
[3] Abhinav A Shukla,et al. Recent advances in large-scale production of monoclonal antibodies and related proteins. , 2010, Trends in biotechnology.
[4] Scott A. Bradley,et al. Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy. , 2010, Journal of the American Chemical Society.
[5] B. Shah,et al. Comparison of N‐Linked Oligosaccharides of Recombinant Human Tissue Kallikrein Produced by Chinese Hamster Ovary Cells on Microcarrier Beads and in Serum‐Free Suspension Culture , 1994, Biotechnology progress.
[6] Takeshi Kobayashi,et al. Effects of Oxygen Aeration on Production of Monoclonal Antibody in Immobilized Hybridoma-Cell Bioreactor , 1990 .
[7] Anurag S. Rathore,et al. Chemometrics applications in biotech processes: Assessing process comparability , 2012, Biotechnology progress.
[8] John R. Engen,et al. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars , 2012, Nature Reviews Drug Discovery.
[9] S Vaidyanathan,et al. Assessment of near-infrared spectral information for rapid monitoring of bioprocess quality. , 2001, Biotechnology and bioengineering.
[10] T. Raju,et al. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. , 2000, Glycobiology.
[11] Anurag S Rathore,et al. Chemometrics applications in biotechnology processes: Predicting column integrity and impurity clearance during reuse of chromatography resin , 2012, Biotechnology progress.
[12] P. Parren,et al. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. , 2008, Blood.
[13] Ali Cinar,et al. Statistical monitoring of multistage, multiphase batch processes , 2002 .
[14] A. Bull,et al. Monitoring recombinant human interferon‐gamma N‐glycosylation during perfused fluidized‐bed and stirred‐tank batch culture of CHO cells , 1998, Biotechnology and bioengineering.
[15] Wei-Shou Hu,et al. Cell culture technology for pharmaceutical and cell-based therapies , 2005 .
[16] M. Butler,et al. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. , 2000, Biotechnology and bioengineering.
[17] M. Butler,et al. The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous culture. , 1997, Biotechnology and bioengineering.
[18] M M Alvarez,et al. Use of a Plackett–Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells , 2011, Biotechnology progress.
[19] Michael Butler,et al. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals , 2005, Applied Microbiology and Biotechnology.
[20] M. Butler,et al. Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.
[21] A. Rathore,et al. Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.
[22] C. Goochee,et al. The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.
[23] M. Moo-young,et al. Statistical methods in media optimization for batch and fed-batch animal cell culture , 2007, Bioprocess and biosystems engineering.
[24] Arushi Arora,et al. Guidance for performing multivariate data analysis of bioprocessing data: Pitfalls and recommendations , 2014, Biotechnology progress.
[25] D. Burton,et al. Sugar Determines Antibody Activity , 2006, Science.
[26] Anurag S Rathore,et al. Application of near‐infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein , 2009, Biotechnology progress.
[27] Z. Li,et al. Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.
[28] Nigel Jenkins,et al. Effect of lipid supplements on the production and glycosylation of recombinant interferon-γ expressed in CHO cells , 2004, Cytotechnology.
[29] D. Bracewell,et al. Impact of aeration strategy on CHO cell performance during antibody production , 2013, Biotechnology progress.
[30] Gyun Min Lee,et al. Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. , 2003, Biotechnology and bioengineering.
[31] Theodora Kourti,et al. Comparing alternative approaches for multivariate statistical analysis of batch process data , 1999 .
[32] H. Gabius,et al. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2,6GalNAc. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Hoy,et al. Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. , 2000, Biotechnology and bioengineering.
[34] R. Wagner,et al. Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. , 1999, Biotechnology and bioengineering.
[35] L. S. Young,et al. Effect of process change from perfusion to fed-batch on product comparability for biosimilar monoclonal antibody , 2012 .
[36] Jarka Glassey,et al. An assessment of seed quality and its influence on productivity estimation in an industrial antibiotic fermentation. , 2002, Biotechnology and bioengineering.
[37] Mariana Henriques,et al. Glycosylation: impact, control and improvement during therapeutic protein production , 2014, Critical reviews in biotechnology.
[38] J. Engasser,et al. Influence of amino acids on hybridoma cell viability and antibody secretion , 1989, Cytotechnology.
[39] F. Gòdia,et al. Analysis of Nutritional Factors and Physical Conditions Affecting Growth and Monoclonal Antibody Production of the Hybridoma KB‐26.5 Cell Line , 1996, Biotechnology progress.
[40] F. Regnier,et al. Rapid process monitoring in biotechnology. , 1993, Trends in biotechnology.
[41] Anurag S. Rathore,et al. Chemometrics application in biotech processes: assessing comparability across processes and scales , 2014 .
[42] A. Rathore,et al. Application of Multivariate Data Analysis for Identification and Successful Resolution of a Root Cause for a Bioprocessing Application , 2008, Biotechnology progress.
[43] C. Goochee,et al. The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. , 1994, Current opinion in biotechnology.
[44] C. Agarabi,et al. Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture , 2013, Biotechnology progress.
[45] P. V. van Berkel,et al. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose , 2011, Biotechnology and bioengineering.
[46] M. Butler,et al. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.
[47] H. Gabius,et al. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acidα2,6GalNAc , 2005 .